TCT 23: 5Y Outcomes From the PARTNER 3 Low-Risk Trial
8:47
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
10:29
Overview of PARTNER 3 & Evolut Low Risk TAVR Trials
1:01:18
TNR - Steroids and PMR
7:31
Self- vs balloon-expandable TAVR in patients with small aortic annuli: SMART trial primary outcomes
6:25
AF Symposium 25: 4 Trials That Will Change My Practice
1:31:48
Understanding the Expanded Risk-Need-Responsivity Model, Supervision, Programming, and Dosage
26:47
Alice Weidel - die AfD-Chefin im Porträt
19:46